ANDERSON KAREN M. (Chief People Officer) sold 65.9% of their position (120.03K shares) of CENTESSA PHARMACEUTICALS PLC on the open market
Open‑market sale worth $3.15M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/13/2026ACC: 0001470831-26-000268
Officer· Chief People Officer
Since Mar 2026
-120.03K
Net shares
Net seller
$3.15M
Total sold
2
Open market trades
0B · 2S
4
Total transactions
109.40K acquired · 229.43K disposed
Non-Derivative Transactions3
Ordinary Shares
Direct
Shares
+109.40K
Price / share
$4.01
Trade value
$438.69K
% of position
150.4%
3/13/2026
72.72K→182.11K
Ordinary Shares
Direct
Shares
−107.96K
Price / share
$26.15
Trade value
$2.82M
% of position
59.3%
3/13/2026
182.11K→74.15K
Ordinary Shares
Direct
Shares
−12.07K
Price / share
$27.13
Trade value
$327.44K
% of position
16.3%
3/13/2026
74.15K→62.09K
Total
Net shares
−10.63K
Net value
-$2.71M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 3/13/2026 | M · Option Exercise | +109.40K | $4.01 | $438.69K | 150.4% | 72.72K | 182.11K |
| Ordinary Shares Direct | 3/13/2026 | S · Sale | −107.96K | $26.15 | $2.82M | 59.3% | 182.11K | 74.15K |
| Ordinary Shares Direct | 3/13/2026 | S · Sale | −12.07K | $27.13 | $327.44K | 16.3% | 74.15K | 62.09K |
| Total | −10.63K | -$2.71M | ||||||
Derivative Transactions1
Share Option (right to buy)
Direct
Converts to
Ordinary Shares
109.40K shares
Shares
−109.40K
Strike price
4.01
Held after
134.64K
Exercisable
—
3/13/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Share Option (right to buy) Direct | Ordinary Shares109.40K shares | 3/13/2026 | M · Option Exercise | −109.40K | 4.01 | — | 134.64K |